Expert Consensus Statement on Pacemaker Device and Mode Selection Developed in partnership between the Heart Rhythm Society ( HRS ) and the American College of Cardiology Foundation ( ACCF ) and in collaboration with the Society of Thoracic Surgeons
暂无分享,去创建一个
A. Russo | K. Ellenbogen | W. Shen | A. Gillis | S. Al‐Khatib | J. Mccomb | J. Nielsen | B. Olshansky | C. Swerdlow | J. Beshai | J. Philpott | J. McComb | W. Shen
[1] A. J. Fuenmayor,et al. Ventricular repolarization during uni and biventricular pacing in normal subjects. , 2013, International journal of cardiology.
[2] W. Shen,et al. Method of Pacing Does Not Affect the Recurrence of Syncope in Carotid Sinus Syndrome , 2012, Pacing and clinical electrophysiology : PACE.
[3] W. Toff,et al. Atrial fibrillation in patients with sick sinus syndrome: the association with PQ-interval and percentage of ventricular pacing. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[4] A. Capucci,et al. Subclinical atrial fibrillation and the risk of stroke. , 2012, The New England journal of medicine.
[5] G. Lamas,et al. The Influence of Atrial and Ventricular Pacing on the Incidence of Atrial Fibrillation: A Meta‐Analysis , 2011, Pacing and clinical electrophysiology : PACE.
[6] G. Lloyd,et al. The relationship between right ventricular pacing and atrial fibrillation burden and disease progression in patients with paroxysmal atrial fibrillation: the long-MinVPACE study. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[7] Silvia G Priori,et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2011, Circulation.
[8] W. Toff,et al. A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome. , 2011, European heart journal.
[9] A. Moss,et al. Long-term implications of cumulative right ventricular pacing among patients with an implantable cardioverter-defibrillator. , 2011, Heart rhythm.
[10] M. Chauvin,et al. Outcome of patients aged over 75 years who received a pacemaker to treat sinus node dysfunction. , 2011, Archives of Cardiovascular Diseases.
[11] D. Slotwiner,et al. Frequent Recurrent Polymorphic Ventricular Tachycardia during Sleep Due to Managed Ventricular Pacing , 2009, Pacing and clinical electrophysiology : PACE.
[12] S. Ouali,et al. DDD versus VVIR Pacing in Patients, Ages 70 and Over, with Complete Heart Block , 2009, Pacing and clinical electrophysiology : PACE.
[13] Dongfeng Qi,et al. The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk: The TRENDS Study , 2009, Circulation. Arrhythmia and electrophysiology.
[14] Jeroen J. Bax,et al. The effects of right ventricular apical pacing on ventricular function and dyssynchrony implications for therapy. , 2009, Journal of the American College of Cardiology.
[15] Harlan M Krumholz,et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Journal of the American College of Cardiology.
[16] G. Guyatt,et al. Going from evidence to recommendations , 2008, BMJ : British Medical Journal.
[17] K. Tscheliessnigg,et al. Percent ventricular pacing with managed ventricular pacing mode in standard pacemaker population. , 2008, Europace.
[18] H. Jensen,et al. DDD(R)-pacing, but not AAI(R)-pacing induces left ventricular desynchronization in patients with sick sinus syndrome: tissue-Doppler and 3D echocardiographic evaluation in a randomized controlled comparison. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[19] A. Ward,et al. Economic and health consequences of managing bradycardia with dual-chamber compared to single-chamber ventricular pacemakers in Italy , 2008, Journal of cardiovascular medicine.
[20] M. Zellweger,et al. Value of VDD-pacing systems in patients with atrioventricular block: experience over a decade. , 2007, International journal of cardiology.
[21] G. Lamas,et al. Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease. , 2007, The New England journal of medicine.
[22] G. Lamas,et al. Impact of rate-modulated pacing on quality of life and exercise capacity--evidence from the Advanced Elements of Pacing Randomized Controlled Trial (ADEPT). , 2007, Heart rhythm.
[23] Paul A. Belk,et al. Bradycardia pacing-induced short-long-short sequences at the onset of ventricular tachyarrhythmias: a possible mechanism of proarrhythmia? , 2007, Journal of the American College of Cardiology.
[24] J. Healey,et al. The effect of atrial-based pacing on exercise capacity as measured by the 6-minute walk test: a substudy of the Canadian Trial of Physiological Pacing (CTOPP). , 2007, Heart rhythm.
[25] K. Stolen,et al. Eliminating right ventricular pacing may not be best for patients requiring implantable cardioverter-defibrillators. , 2007, Heart rhythm.
[26] M. Brignole,et al. Analysis of rhythm variation during spontaneous cardioinhibitory neurally-mediated syncope. Implications for RDR pacing optimization: an ISSUE 2 substudy. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[27] E. Minder,et al. Single-chamber ventricular pacing increases markers of left ventricular dysfunction compared with dual-chamber pacing. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[28] J. Day,et al. Is Dual-Chamber Programming Inferior to Single-Chamber Programming in an Implantable Cardioverter-Defibrillator?: Results of the INTRINSIC RV (Inhibition of Unnecessary RV Pacing With AVSH in ICDs) Study , 2006, Circulation.
[29] I. V. Van Gelder,et al. Right ventricular pacing and the risk of heart failure in implantable cardioverter-defibrillator patients. , 2006, Heart rhythm.
[30] A. Gillis. Redefining physiologic pacing: lessons learned from recent clinical trials. , 2006, Heart rhythm.
[31] R. van Mechelen,et al. Risk of managed ventricular pacing in a patient with heart block. , 2006, Heart rhythm.
[32] W. Boute,et al. Retrospective analysis of mode survival, reliability of atrial sensing and incidence of atrial tachyarrhythmias in 307 single-lead VDD pacemaker patients. , 2006, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[33] L. Goldman,et al. Cardiovascular Outcomes With Atrial-Based Pacing Compared With Ventricular Pacing: Meta-Analysis of Randomized Trials, Using Individual Patient Data , 2006, Circulation.
[34] C. Israel,et al. Reducing Unnecessary Right Ventricular Pacing with the Managed Ventricular Pacing Mode in Patients with Sinus Node Disease and AV Block , 2006, Pacing and clinical electrophysiology : PACE.
[35] Alexandra Ward,et al. Modelling the health benefits and economic implications of implanting dual-chamber vs. single-chamber ventricular pacemakers in the UK. , 2006, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[36] L. Goldman,et al. Pacemaker implantation and quality of life in the Mode Selection Trial (MOST). , 2006, Heart rhythm.
[37] L. Di Biase,et al. Is a Dual‐Sensor Pacemaker Appropriate in Patients with Sino‐Atrial Disease? Results from the DUSISLOG Study , 2006, Pacing and clinical electrophysiology : PACE.
[38] M. Pitt,et al. The effectiveness and cost-effectiveness of dual-chamber pacemakers compared with single-chamber pacemakers for bradycardia due to atrioventricular block or sick sinus syndrome: systematic review and economic evaluation. , 2005, Health technology assessment.
[39] A. Young,et al. The effect of pacemaker mode on cognitive function , 2005, Heart.
[40] K. Ellenbogen,et al. Multicenter, Prospective, Randomized Safety and Efficacy Study of a New Atrial‐Based Managed Ventricular Pacing Mode (MVP) in Dual Chamber ICDs , 2005, Journal of cardiovascular electrophysiology.
[41] Arjun D. Sharma,et al. Percent right ventricular pacing predicts outcomes in the DAVID trial. , 2005, Heart rhythm.
[42] A. Gillis,et al. High atrial antitachycardia pacing therapy efficacy is associated with a reduction in atrial tachyarrhythmia burden in a subset of patients with sinus node dysfunction and paroxysmal atrial fibrillation. , 2005, Heart rhythm.
[43] A. Camm,et al. Single-chamber versus dual-chamber pacing for high-grade atrioventricular block. , 2005, The New England journal of medicine.
[44] Paul J. Wang,et al. The Clinical Implications of Cumulative Right Ventricular Pacing in the Multicenter Automatic Defibrillator Trial II , 2005, Journal of cardiovascular electrophysiology.
[45] B. O'brien,et al. Cost-effectiveness of physiologic pacing: results of the Canadian Health Economic Assessment of Physiologic Pacing. , 2005, Heart rhythm.
[46] L. Goldman,et al. Cost-Effectiveness of Dual-Chamber Pacing Compared With Ventricular Pacing for Sinus Node Dysfunction , 2005, Circulation.
[47] R. Kenny,et al. Individualised quality of life after pacing. Does mode matter? , 2004, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[48] M. Brignole,et al. A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE). , 2004, European heart journal.
[49] C. Morillo,et al. The World Survey of Cardiac Pacing and Cardioverter Defibrillators: Calendar Year 2001 , 2004, Pacing and clinical electrophysiology : PACE.
[50] L. Goldman,et al. High incidence of pacemaker syndrome in patients with sinus node dysfunction treated with ventricular-based pacing in the Mode Selection Trial (MOST). , 2004, Journal of the American College of Cardiology.
[51] G. Lip,et al. Dual chamber versus single chamber ventricular pacemakers for sick sinus syndrome and atrioventricular block. , 2004, The Cochrane database of systematic reviews.
[52] S. Connolly,et al. Canadian Trial of Physiological Pacing: Effects of Physiological Pacing During Long-Term Follow-Up , 2004, Circulation.
[53] S. Connolly,et al. Second Vasovagal Pacemaker Study (VPS II): rationale, design, results, and implications for practice and future clinical trials. , 2003, Cardiac electrophysiology review.
[54] D. Wyse,et al. Total Atrioventricular Nodal Ablation Increases Atrial Fibrillation Burden in Patients with Paroxysmal Atrial Fibrillation Despite Continuation of Antiarrhythmic Drug Therapy , 2003, Journal of cardiovascular electrophysiology.
[55] G. Lamas,et al. Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction , 2003, Circulation.
[56] S. Connolly,et al. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial. , 2003, JAMA.
[57] S. Connolly,et al. Effect of pacing mode on health-related quality of life in the Canadian Trial of Physiologic Pacing. , 2003, American heart journal.
[58] David O. Martin,et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. , 2002, JAMA.
[59] L. Goldman,et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. , 2002, The New England journal of medicine.
[60] A. Gillis,et al. Atrial Fibrillation After DDDR Pacemaker Implantation , 2002, Journal of cardiovascular electrophysiology.
[61] R. Verlato,et al. An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation. , 2002, European heart journal.
[62] S. Juul-Möller,et al. Improved cardiac function and quality of life following upgrade to dual chamber pacing after long-term ventricular stimulation. , 2002, European heart journal.
[63] S. Connolly,et al. Progression to chronic atrial fibrillation after pacing: the Canadian Trial of Physiologic Pacing. CTOPP Investigators. , 2001, Journal of the American College of Cardiology.
[64] S. Connolly,et al. Relationship Between Pacemaker Dependency and the Effect of Pacing Mode on Cardiovascular Outcomes , 2001, Circulation.
[65] H. Mond. The World Survey of Cardiac Pacing and Cardioverter Defibrillators: Calendar Year 1997 , 2001, Pacing and clinical electrophysiology : PACE.
[66] J. Nielsen,et al. AV Block and Changes in Pacing Mode During Long‐Term Follow‐Up of 399 Consecutive Patients with Sick Sinus Syndrome Treated with an AAI/AAIR Pacemaker , 2001, Pacing and clinical electrophysiology : PACE.
[67] S. Connolly,et al. Randomized crossover comparison of DDDR versus VDD pacing after atrioventricular junction ablation for prevention of atrial fibrillation. The atrial pacing peri-ablation for paroxysmal atrial fibrillation (PA (3)) study investigators. , 2000, Circulation.
[68] A. Gillis,et al. Whither Physiologic Pacing? Implications of CTOPP , 2000, Pacing and clinical electrophysiology : PACE.
[69] G. Lamas,et al. Clinical characteristics of patients intolerant to VVIR pacing. , 2000, The American journal of cardiology.
[70] M Gent,et al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes , 2000 .
[71] Randall G. Brockman,et al. Acute hemodynamic effects of right ventricular pacing site and pacing mode in patients with congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. , 2000, The American journal of cardiology.
[72] G. Kay,et al. Clinical outcomes after ablation and pacing therapy for atrial fibrillation : a meta-analysis. , 2000, Circulation.
[73] J. Nanas,et al. Congestive heart failure treated by the upgrade from VVI to DDD pacing , 2000, Acta cardiologica.
[74] M. Josephson,et al. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY). , 1999, Circulation.
[75] R. Holder,et al. Prospective randomized study of ablation and pacing versus medical therapy for paroxysmal atrial fibrillation: effects of pacing mode and mode-switch algorithm. , 1999, Circulation.
[76] L. Thuesen,et al. Atrioventricular conduction during long-term follow-up of patients with sick sinus syndrome. , 1998, Circulation.
[77] L. Goldman,et al. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. , 1998, Pacing and clinical electrophysiology : PACE.
[78] M. Petch,et al. Ventricular pacemaker upgrade: experience, complications and recommendations , 1998, Heart.
[79] L. Thuesen,et al. Heart failure and echocardiographic changes during long-term follow-up of patients with sick sinus syndrome randomized to single-chamber atrial or ventricular pacing. , 1998, Circulation.
[80] M. Brignole,et al. Progression of permanent atrial fibrillation after atrioventricular junction ablation and dual-chamber pacemaker implantation in patients with paroxysmal atrial tachyarrhythmias. , 1998, The American journal of cardiology.
[81] L. Thuesen,et al. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome , 1997, The Lancet.
[82] W. Mckenna,et al. Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC Study Group. , 1997, European heart journal.
[83] C. Bucknall,et al. Is mode switching beneficial? A randomized study in patients with paroxysmal atrial tachyarrhythmias. , 1997, Journal of the American College of Cardiology.
[84] R. Kenny,et al. A study comparing VVI and DDI pacing in elderly patients with carotid sinus syndrome. , 1997, Heart.
[85] C. Morillo,et al. The pacemaker syndrome -- a matter of definition. , 1997, The American journal of cardiology.
[86] A. Tajik,et al. Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial. , 1997, Journal of the American College of Cardiology.
[87] C. Morillo,et al. Higher sympathetic nerve activity during ventricular (VVI) than during dual-chamber (DDD) pacing. , 1996, Journal of the American College of Cardiology.
[88] L. Jordaens,et al. A Randomized, Single‐Blind Crossover Comparison of the Effects of Chronic DDD and Dual Sensor VVIR Pacing Mode on Quality‐of‐ Life and Cardiopulmonary Performance in Complete Heart Block , 1996, Pacing and clinical electrophysiology : PACE.
[89] K. Channon,et al. Comparison of dual chamber and ventricular rate responsive pacing in patients over 75 with complete heart block. , 1995, British heart journal.
[90] C. Leclercq,et al. Hemodynamic importance of preserving the normal sequence of ventricular activation in permanent cardiac pacing. , 1995, American heart journal.
[91] B. Nowak,et al. Cardiac output in single-lead VDD pacing versus rate-matched VVIR pacing. , 1995, The American journal of cardiology.
[92] A. Tajik,et al. Mechanism of hemodynamic improvement by dual-chamber pacing for severe left ventricular dysfunction: an acute Doppler and catheterization hemodynamic study. , 1995, Journal of the American College of Cardiology.
[93] B. Grubb,et al. Cardiac Pacing for Prevention of Recurrent Vasovagal Syncope , 1995, Annals of Internal Medicine.
[94] D Tripodi,et al. Long‐term Results of Dual‐Chamber (DDD) Pacing in Obstructive Hypertrophic Cardiomyopathy: Evidence for Progressive Symptomatic and Hemodynamic Improvement and Reduction of Left Ventricular Hypertrophy , 1994, Circulation.
[95] J. Lukl,et al. Quality‐of‐Life During DDD and Dual Sensor VVIR Pacing , 1994, Pacing and clinical electrophysiology : PACE.
[96] C. Lau,et al. Quality‐of‐Life in DDDR Pacing: Atrioventricular Synchrony or Rate Adaptation? , 1994, Pacing and clinical electrophysiology : PACE.
[97] M. Buchalter,et al. Physiological pacing improves symptoms and increases exercise capacity in the elderly patient. , 1994, International journal of cardiology.
[98] S. Deshpande,et al. Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole. , 1993, The New England journal of medicine.
[99] G. V. Van Hare,et al. Combined use of beta-adrenergic blocking agents and long-term cardiac pacing for patients with the long QT syndrome. , 1992, Journal of the American College of Cardiology.
[100] H. Schüller,et al. Natural history of sinus node disease treated with atrial pacing in 213 patients: implications for selection of stimulation mode. , 1992, Journal of the American College of Cardiology.
[101] D Tripodi,et al. Impact of Dual‐Chamber Permanent Pacing in Patients With Obstructive Hypertrophic Cardiomyopathy With Symptoms Refractory to Verapamil and β‐Adrenergic Blocker Therapy , 1992, Circulation.
[102] M. Brignole,et al. Long-term outcome of paced and nonpaced patients with severe carotid sinus syndrome. , 1992, The American journal of cardiology.
[103] M. Rosenqvist,et al. Longevity in Patients With High Degree Atrioventricular Block Paced in the Atrial Synchronous or the Fixed Rate Ventricular Inhibited Mode , 1992, Pacing and clinical electrophysiology : PACE.
[104] E. Sowton,et al. "Subclinical" pacemaker syndrome: a randomised study of symptom free patients with ventricular demand (VVI) pacemakers upgraded to dual chamber devices. , 1992, British heart journal.
[105] A. Moss,et al. Efficacy of Permanent Pacing in the Management of High‐Risk Patients With Long QT Syndrome , 1991, Circulation.
[106] K. Oldroyd,et al. Double blind crossover comparison of the effects of dual chamber pacing (DDD) and ventricular rate adaptive (VVIR) pacing on neuroendocrine variables, exercise performance, and symptoms in complete heart block. , 1991, British heart journal.
[107] N Sulke,et al. A randomized double-blind crossover comparison of four rate-responsive pacing modes. , 1991, Journal of the American College of Cardiology.
[108] J. Messenger,et al. True Incidence of Pacemaker Syndrome , 1990, Pacing and clinical electrophysiology : PACE.
[109] M. Brignole,et al. Ventricular and Dual Chamber Pacing for Treatment of Carotid Sinus Syndrome , 1989, Pacing and clinical electrophysiology : PACE.
[110] Bredikis IuIu,et al. [The pacemaker syndrome]. , 1988, Kardiologiia.
[111] D. Lipkin,et al. The role of exercise testing in chronic heart failure. , 1987, British heart journal.
[112] M. Eldar,et al. Permanent cardiac pacing in patients with the long QT syndrome. , 1987, Journal of the American College of Cardiology.
[113] J. Johnston,et al. A comparison of symptoms and intra-arterial ambulatory blood pressure during long term dual chamber atrioventricular synchronous (DDD) and ventricular demand (VVI) pacing. , 1987, British heart journal.
[114] R. Kenny,et al. The Natural History of Sick Sinus Syndrome , 1986, Pacing and clinical electrophysiology : PACE.
[115] A. Abdulla,et al. Management of cardioinhibitory hypersensitive carotid sinus syncope with permanent cardiac pacing--a seventeen year prospective study. , 1985, The Canadian journal of cardiology.
[116] R. Sutton,et al. Randomised controlled trial of physiological and ventricular pacing. , 1983, British heart journal.
[117] R. Sutton,et al. Carotid sinus syncope treated by pacing. Analysis of persistent symptoms and role of atrioventricular sequential pacing. , 1982, British heart journal.
[118] L. Rydén,et al. A Comparison of the Acute and Long‐term Hemodynamic Effects of Ventricular Inhibited and Atrial Synchronous Ventricular Inhibited Pacing , 1982, Circulation.
[119] William T. Abraham,et al. Focused Update : ACCF / AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults , 2013 .
[120] Finn Gustafsson,et al. 2010 Focused Update of ESC Guidelines on Device Therapy in Heart Failure , 2011 .
[121] M. Gold. Complication Rates Associated With Pacemaker or Implantable Cardioverter-Defibrillator Generator Replacements and Upgrade Procedures: Results From the REPLACE Registry , 2011 .
[122] M. Gold,et al. Long-term Outcomes in Individuals With Prolonged PR Interval or First-Degree Atrioventricular Block , 2010 .
[123] M. Brignole,et al. International study on syncope of uncertain aetiology 3 (ISSUE 3): pacemaker therapy for patients with asystolic neurally-mediated syncope: rationale and study design. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[124] D. Massel,et al. The expectation effect and cardiac pacing for refractory vasovagal syncope. , 2007, The American journal of medicine.
[125] G. Gribbin,et al. Chronic atrial fibrillation in patients with paroxysmal atrial fibrillation, atrioventricular node ablation and pacemakers: determinants and treatment. , 1999, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[126] S. Connolly,et al. The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. , 1999, Journal of the American College of Cardiology.
[127] K. Channon,et al. DDD vs. VVI pacing in patients aged over 75 years with complete heart block: a double-blind crossover comparison. , 1994, The Quarterly journal of medicine.
[128] K. Ellenbogen,et al. New insights into pacemaker syndrome gained from hemodynamic, humoral and vascular responses during ventriculo-atrial pacing. , 1990, The American journal of cardiology.
[129] GrADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2022 .